Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep

Sleep Medicine

Volumn 4, Issue 2, 2003, Pages 153-155

  Santamaria, Joan ^a   Iranzo, Alex ^a   Tolosa, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

L dopa; Pergolide; Periodic leg movements in sleep; Restless legs augmentation; Restless legs syndrome

Indexed keywords

BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; LEVODOPA; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FERRITIN BLOOD LEVEL; HUMAN; LEG MOVEMENT; MALE; MOTOR DYSFUNCTION; PATHOGENESIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP; SYMPTOM; WAKEFULNESS;

EID: 0038071543     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(02)00153-3     Document Type: Article

References (11)

1. Montplaisir J, Michaud M, Denesle R, Gosselin A. Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep Med 2000;1:163-7.
2. Allen RP, Earley CJ. Restless legs syndrome. A review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-47.
3. Montplaisir J, Boucher S, Poirier G, Lavigne G, et al. Clinical, polysomnogrpahic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-5.
4. Mahowald M. Assessment of periodic leg movements is not an essential component of an overnight sleep study. Am J Respir Crit Care Med 2001;164:1340-1.
5. Walters AS. Assessment of periodic leg movements is an essential component of an overnight sleep study. Am J Resp Crit Care Med 2001;164:1339-440.
6. Silber MH. Commentary on controversies in sleep medicine Montplaisir et al.: periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic mechanism. Sleep Med 2001;2:367-9.
7. Allen RP, Early CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-13.
8. Walters AS. Towards a better definition of the restless legs syndrome. The international restless legs syndrome study group. Mov Disord 1995;10:634-42.
9. Earley CJ, Connor JR, Beard JL, Malecki EA, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-700.
10. Allen RP, Barker PB, Wehrl F, Song HK, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-5.
11. Earley CJ, Allen RP. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep 1996;19:801-10.